These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28121626)

  • 21. Distribution of CD44/CD24 positive cells in ductal invasive carcinoma of breast of different grade and molecular subtype.
    Gudadze M; Kankava K; Mariamidze A; Mosidze T; Burkadze G
    Georgian Med News; 2013 Sep; (222):50-7. PubMed ID: 24099815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
    Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
    Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semi-quantitative evaluation of CD44(+) /CD24(-) tumor cell distribution in breast cancer tissue using a newly developed fluorescence immunohistochemical staining method.
    Kai M; Onishi H; Souzaki M; Tanaka H; Kubo M; Tanaka M; Katano M
    Cancer Sci; 2011 Dec; 102(12):2132-8. PubMed ID: 21838786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human colorectal CD24+ cancer stem cells are susceptible to epithelial-mesenchymal transition.
    Okano M; Konno M; Kano Y; Kim H; Kawamoto K; Ohkuma M; Haraguchi N; Yokobori T; Mimori K; Yamamoto H; Sekimoto M; Doki Y; Mori M; Ishii H
    Int J Oncol; 2014 Aug; 45(2):575-80. PubMed ID: 24858473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
    Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
    J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Significance of CD24 in Clear Cell Renal Cell Carcinoma.
    Arik D; Can C; Dündar E; Kabukçuoğlu S; Paşaoğlu Ö
    Pathol Oncol Res; 2017 Apr; 23(2):409-416. PubMed ID: 27738793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
    Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H
    J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial cells provide a notch-dependent pro-tumoral niche for enhancing breast cancer survival, stemness and pro-metastatic properties.
    Ghiabi P; Jiang J; Pasquier J; Maleki M; Abu-Kaoud N; Rafii S; Rafii A
    PLoS One; 2014; 9(11):e112424. PubMed ID: 25380486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.
    Reim F; Dombrowski Y; Ritter C; Buttmann M; Häusler S; Ossadnik M; Krockenberger M; Beier D; Beier CP; Dietl J; Becker JC; Hönig A; Wischhusen J
    Cancer Res; 2009 Oct; 69(20):8058-66. PubMed ID: 19826050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells.
    Ponnurangam S; Dandawate PR; Dhar A; Tawfik OW; Parab RR; Mishra PD; Ranadive P; Sharma R; Mahajan G; Umar S; Weir SJ; Sugumar A; Jensen RA; Padhye SB; Balakrishnan A; Anant S; Subramaniam D
    Oncotarget; 2016 Jan; 7(3):3217-32. PubMed ID: 26673007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD24 and CD44 in salivary gland pleomorphic adenoma and in human salivary gland morphogenesis: differential markers of glandular structure or stem cell indicators?
    Ianez RC; Coutinho-Camillo CM; Buim ME; Pinto CA; Soares FA; Lourenço SV
    Histopathology; 2013 Jun; 62(7):1075-82. PubMed ID: 23600676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD44+/CD24- Cancer Stem Cells Are Associated With Higher Grade of Canine Mammary Carcinomas.
    Im KS; Jang YG; Shin JI; Kim NH; Lim HY; Lee SM; Kim JH; Sur JH
    Vet Pathol; 2015 Nov; 52(6):1041-4. PubMed ID: 26173453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal carcinoma CD105-/CD44- cells display stem-like properties in vitro and form aggressive tumors in vivo.
    Fiedorowicz M; Khan MI; Strzemecki D; Orzeł J; Wełniak-Kamińska M; Sobiborowicz A; Wieteska M; Rogulski Z; Cheda L; Wargocka-Matuszewska W; Kilian K; Szczylik C; Czarnecka AM
    Sci Rep; 2020 Mar; 10(1):5379. PubMed ID: 32214151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75 NTR in malignancy.
    Dalley AJ; AbdulMajeed AA; Upton Z; Farah CS
    J Oral Pathol Med; 2013 Jan; 42(1):37-46. PubMed ID: 22643025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD44 as a molecular marker to screen cancer stem cells in hypopharyngeal cancer.
    Shen C; Xiang M; Nie C; Hu H; Ma Y; Wu H
    Acta Otolaryngol; 2013 Nov; 133(11):1219-26. PubMed ID: 23837451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Hedgehog signaling pathway plays an essential role in maintaining the CD44+CD24-/low subpopulation and the side population of breast cancer cells.
    Tanaka H; Nakamura M; Kameda C; Kubo M; Sato N; Kuroki S; Tanaka M; Katano M
    Anticancer Res; 2009 Jun; 29(6):2147-57. PubMed ID: 19528475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.
    de Beça FF; Caetano P; Gerhard R; Alvarenga CA; Gomes M; Paredes J; Schmitt F
    J Clin Pathol; 2013 Mar; 66(3):187-91. PubMed ID: 23112116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-met inhibition blocks bone metastasis development induced by renal cancer stem cells.
    D'Amico L; Belisario D; Migliardi G; Grange C; Bussolati B; D'Amelio P; Perera T; Dalmasso E; Dalle Carbonare L; Godio L; Comoglio P; Trusolino L; Ferracini R; Roato I
    Oncotarget; 2016 Jul; 7(29):45525-45537. PubMed ID: 27322553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
    Shao J; Fan W; Ma B; Wu Y
    Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.